risedronic acid has been researched along with Amyotonia Congenita in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hozuki, T | 1 |
| Imai, T | 1 |
| Tsuda, E | 1 |
| Matsumura, A | 1 |
| Yamamoto, D | 1 |
| Toyoshima, T | 1 |
| Suzuki, S | 1 |
| Yamauchi, R | 1 |
| Hayashi, T | 1 |
| Hisahara, S | 1 |
| Shimohama, S | 1 |
1 trial available for risedronic acid and Amyotonia Congenita
| Article | Year |
|---|---|
Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Biomarkers; Bone and Bones; Bone Density; Bone Density Conserv | 2010 |